By MEGGLE Excipients
To get in touch with MEGGLE Excipients, simply fill out the form below.
Subscribe to Supplier
MEGGLE present as sponsor at IPEC Europe 2021 virtual event
Wasserburg, Germany: – Pharmaceutical lactose specialist MEGGLE Wasserburg GmbH (MEGGLE) will be a high profile presence at the upcoming online 9th annual meeting of the International Pharmaceutical Excipients Council Europe (IPEC Europe), both as a sponsor and participant.
The event will give MEGGLE an opportunity to share latest knowledge on its very wide range of advanced co-processed and tailored formulations, including its recently introduced InhaLac® 300.
The event is co-hosted by the International Association for Pharmaceutical Technology (APV). As one of Europe’s leading excipients producers, MEGGLE Wasserburg has a long standing relationship with both organizations.
IPEC Europe attracts particular groups of professionals working in the excipients field including purchasing, development, manufacture and quality, distribution and sales, supplier qualification, and application and control for medicinal products, along with representatives from regulatory authorities and purchasing departments.
MEGGLE will have a virtual booth at the online event, live streamed over two days from IPEC’s offices in Brussels. The booth will be staffed by an expert team, including Application Manager Dr. Sabine Friedlhuber, who will be able to help with technical queries and guide visitors on MEGGLE’s extensive range of lactose-based excipients.
Latest excipient innovations
“We are very much looking forward to participating in this valuable event, which is perfectly focused on our field of activity and our target group,” said Dr. Friedlhuber.
“This is an important event for presentation and discussion of the latest standards and innovations in the excipient field and Meggle is delighted to support IPEC Europe as a sponsor,” she added.
About MEGGLE Wasserburg
Bavarian-based MEGGLE is one of the world’s experts in co-processing and powder technology. From its roots as a dairy operation in the late 1880’s, MEGGLE has become one of the world’s leading manufacturers of pharmaceutical lactose, supplying the pharma market segment with a broad-based and unique lactose product portfolio.
MEGGLE Excipients & Technology has harnessed outstanding product quality and intelligent innovation to become a global leader in the manufacture of lactose-based excipients, focusing on products for direct tableting and dry powder inhalation.
A multidisciplinary team of committed and highly qualified people allows MEGGLE clients to benefit from pioneering experience and innovative drive in industrial milk and whey processing. The company constantly strives to develop high-tech, functional products for solid dosage forms and DPI applications, where they can deliver maximum performance.
The company has introduced several pioneering products, notably Tablettose®, the world’s first agglomerated lactose for direct tableting, Cellactose® 80, a pioneering co-processed excipient based on cellulose-lactose for outstanding compression and flow properties and RetaLac®, the first direct compression co-processed excipient using a hypromellose-lactose base for sustained release formulations.
To learn more, visit: https://www.meggle-pharma.com/en/home.html
About IPEC Europe Excipients Conference 2021
Founded in 1992, the International Pharmaceutical Excipients Council Europe (IPEC Europe) provides a forum that unites producers, distributors and users of pharmaceutical excipients, with a shared goal to improve excipient quality, safety, and effectiveness.
The 9th IPEC Europe annual conference will be hosted as a virtual event from the Council’s headquarters in Brussels, with live sessions online between 1300 and 1800 hours over two days, opening on September 22.
The conference will focus on regulatory topics relating to pharmaceutical excipients and technology, including regulation in Europe and emerging countries, latest developments from EDQM and USP as well as an outlook into the role of excipients to the year 2025 and beyond. The conference will also focus on material requirements for continuous manufacturing of oral solid dosage forms, as well as potential impact of 3D printing technology.
The event is organized in partnership with the Mainz-based International Association for Pharmaceutical Technology (APV GmbH) with further information at: https://www.ipec-europe.org/events/apv-ie-2021.html
Click on InhaLac brochure to download full product range information
Click on Meggle Product Finder to browse all excipients
Click on Experts in Excipients to download MEGGLE product brochure
Click on MEGGLE Downloads for more brochures